Found: 63
Select item for more details and to access through your institution.
Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study.
- Published in:
- Acta Obstetricia et Gynecologica Scandinavica, 2010, v. 89, n. 10, p. 1338, doi. 10.3109/00016349.2010.512070
- By:
- Publication type:
- Article
Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in the native or posttransplant kidney.
- Published in:
- Nephrology Dialysis Transplantation, 2024, v. 39, n. 5, p. 888, doi. 10.1093/ndt/gfae005
- By:
- Publication type:
- Article
Free light chain testing in follow-up of multiple myeloma.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2006, v. 44, n. 8, p. 1044, doi. 10.1515/CCLM.2006.188
- By:
- Publication type:
- Article
Differentiation Potential of Human Postnatal Mesenchymal Stem Cells, Mesoangioblasts, and Multipotent Adult Progenitor Cells Reflected in Their Transcriptome and Partially Influenced by the Culture Conditions.
- Published in:
- Stem Cells, 2011, v. 29, n. 5, p. 871, doi. 10.1002/stem.633
- By:
- Publication type:
- Article
Development and validation of a novel risk stratification algorithm for relapsed multiple myeloma.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 4, p. 447, doi. 10.1111/bjh.16105
- By:
- Publication type:
- Article
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 6, p. 831, doi. 10.1111/bjh.15092
- By:
- Publication type:
- Article
Multiple myeloma: patient outcomes in real-world practice.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 2, p. 252, doi. 10.1111/bjh.14213
- By:
- Publication type:
- Article
Multiple myeloma: practice patterns across Europe.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 1, p. 66, doi. 10.1111/bjh.14193
- By:
- Publication type:
- Article
Overall survival of relapsed and refractory multiple myeloma patients after adjusting for crossover in the MM-003 trial for pomalidomide plus low-dose dexamethasone.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 6, p. 820, doi. 10.1111/bjh.13227
- By:
- Publication type:
- Article
Ultra‐low depth sequencing of plasma cell DNA for the detection of copy number aberrations in multiple myeloma.
- Published in:
- Genes, Chromosomes & Cancer, 2020, v. 59, n. 8, p. 465, doi. 10.1002/gcc.22848
- By:
- Publication type:
- Article
Impfempfehlungen beim Multiplen Myelom: ein Konsensbericht des European Myeloma Network.
- Published in:
- Kompass Onkologie, 2022, v. 9, n. 1, p. 3, doi. 10.1159/000522451
- By:
- Publication type:
- Article
Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.
- Published in:
- Drugs, 2016, v. 76, n. 9, p. 989, doi. 10.1007/s40265-016-0590-3
- By:
- Publication type:
- Article
Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.
- Published in:
- Drugs, 2016, v. 76, n. 8, p. 853, doi. 10.1007/s40265-016-0573-4
- By:
- Publication type:
- Article
COVID-19, impact on myeloma patients.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Incidence of neutropenia and use of granulocyte colony-stimulating factors in multiple myeloma: is current clinical practice adequate?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Blinatumomab in relapsed/refractory diffuse large B cell lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies
- Published in:
- Annals of Hematology, 2015, v. 94, n. 1, p. 23, doi. 10.1007/s00277-014-2177-y
- By:
- Publication type:
- Article
Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.
- Published in:
- Annals of Hematology, 2011, v. 90, n. 6, p. 655, doi. 10.1007/s00277-011-1164-9
- By:
- Publication type:
- Article
Combined lenalidomide/bortezomib for multiple myeloma complicated by fulminant myocarditis: a rare case report of widely used chemotherapy.
- Published in:
- European Heart Journal Case Reports, 2022, v. 6, n. 3, p. 1, doi. 10.1093/ehjcr/ytac093
- By:
- Publication type:
- Article
Case report: Two sisters with light-chain cardiac amyloidosis, a mere coincidence?
- Published in:
- European Heart Journal Case Reports, 2022, v. 6, n. 2, p. 1, doi. 10.1093/ehjcr/ytac084
- By:
- Publication type:
- Article
Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4359, doi. 10.3390/cancers15174359
- By:
- Publication type:
- Article
Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance: A CMWP‐EBMT study.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 2, p. 181, doi. 10.1111/ejh.13981
- By:
- Publication type:
- Article
Bortezomib‐based therapy for relapsed/refractory multiple myeloma in real‐world medical practice.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 4, p. 556, doi. 10.1111/ejh.13147
- By:
- Publication type:
- Article
Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 3, p. 199, doi. 10.1111/ejh.12903
- By:
- Publication type:
- Article
Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 1, p. 16, doi. 10.1111/j.1600-0609.2012.01788.x
- By:
- Publication type:
- Article
Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma.
- Published in:
- European Journal of Haematology, 2011, v. 86, n. 5, p. 372, doi. 10.1111/j.1600-0609.2011.01599.x
- By:
- Publication type:
- Article
Neutrophil extracellular trap cell death requires both autophagy and superoxide generation.
- Published in:
- Cell Research, 2011, v. 21, n. 2, p. 290, doi. 10.1038/cr.2010.150
- By:
- Publication type:
- Article
Failure of Serum Immunofixation Electrophoresis to Detect Intact Monoclonal IgD Lambda Unraveled by Mass Spectrometry.
- Published in:
- Clinical Chemistry, 2024, v. 70, n. 10, p. 1291, doi. 10.1093/clinchem/hvae116
- By:
- Publication type:
- Article
The novel family of Warbicin® compounds inhibits glucose uptake both in yeast and human cells and restrains cancer cell proliferation.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1411983
- By:
- Publication type:
- Article
Two Cases of Heavy Chain MGUS.
- Published in:
- Case Reports in Oncological Medicine, 2016, p. 1, doi. 10.1155/2016/8749153
- By:
- Publication type:
- Article
Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma: Results From the Phase II MajesTEC-1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 3, p. 194, doi. 10.1016/j.clml.2023.11.001
- By:
- Publication type:
- Article
Predictors of Lenalidomide Refractory Relapse Timing With Newly Diagnosed Multiple Myeloma: A FIRST Trial Subanalysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. e297, doi. 10.1016/j.clml.2023.06.002
- By:
- Publication type:
- Article
P-207: A multi-center, phase 1b study to assess the safety, Pharmacokinetics and efficacy of subcutaneous Isatuximab plus Pomalidomide and Dexamethasone, in patients with Relapsed/Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S152, doi. 10.1016/S2152-2650(21)02334-X
- By:
- Publication type:
- Article
P-187: Expert elicitation of long-term survival (LTS) for patients (pts) with relapsed/refractory multiple myeloma (RRMM) treated with idecabtagene vicleucel (ide-cel, bb2121) in the KarMMa phase 2 trial.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S139, doi. 10.1016/S2152-2650(21)02314-4
- By:
- Publication type:
- Article
P-162: Compass: a prospective study comparing clinical evaluation with different geriatric screening methods in newly diagnosed elderly multiple myeloma patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S124, doi. 10.1016/S2152-2650(21)02289-8
- By:
- Publication type:
- Article
OAB-027: Idecabtagene vicleucel (ide-cel, bb2121), a BCMA-directed CAR T-cell therapy, for the treatment of patients with relapsed and refractory multiple myeloma (RRMM): updated results from KarMMa.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S17, doi. 10.1016/S2152-2650(21)02101-7
- By:
- Publication type:
- Article
OAB-023: Efficacy and safety of ciltacabtagene autoleucel, a BCMA-directed CAR-T cell therapy, in patients with progressive multiple myeloma after 1–3 prior lines of therapy: Initial results from CARTITUDE-2.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S15, doi. 10.1016/S2152-2650(21)02097-8
- By:
- Publication type:
- Article
Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) Delivers a Reduction and Delay in Worsening of Pain Symptoms for Patients with Newly Diagnosed Multiple Myeloma Ineligible for Transplant.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e225, doi. 10.1016/j.clml.2019.09.375
- By:
- Publication type:
- Article
Concordance of Post-consolidation Minimal Residual Disease Rates by Multiparametric Flow Cytometry and Next-generation Sequencing in CASSIOPEIA.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e3, doi. 10.1016/j.clml.2019.09.005
- By:
- Publication type:
- Article
Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e2, doi. 10.1016/j.clml.2019.09.004
- By:
- Publication type:
- Article
Phase 2b Results of the STORM Study: Oral Selinexor plus Low Dose Dexamethasone (Sd) in Patients with Penta-Refractory Myeloma (penta-MM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S249, doi. 10.1016/j.clml.2018.07.149
- By:
- Publication type:
- Article
Low-pass Sequencing of Plasma Cell DNA and of ccfDNA for the Detection of Copy Number Aberrations and Early Response Monitoring in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e95, doi. 10.1016/j.clml.2017.03.170
- By:
- Publication type:
- Article
Effect of Treatment with Lenalidomide Plus Low-Dose Dexamethasone Until Progression on Health-Related Quality of Life Over Time in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e87, doi. 10.1016/j.clml.2017.03.157
- By:
- Publication type:
- Article
Treatment With Doxycycline for Severe Bortezomib-Associated Blepharitis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Renal Thrombotic Microangiopathy Associated with the Use of Bortezomib in a Patient with Multiple Myeloma.
- Published in:
- Case Reports in Hematology, 2016, p. 1, doi. 10.1155/2016/6020691
- By:
- Publication type:
- Article
Monocytes from patients with myelodysplastic syndromes are more resistant to inhibition by thalidomide.
- Published in:
- American Journal of Hematology, 2009, v. 84, n. 11, p. 769, doi. 10.1002/ajh.21529
- By:
- Publication type:
- Article
Target identification of small molecules using large-scale CRISPR-Cas mutagenesis scanning of essential genes.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-017-02349-8
- By:
- Publication type:
- Article
The t(14;20)(q32;q12): a rare cytogenetic change in multiple myeloma associated with poor outcome.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival.
- Published in:
- British Journal of Haematology, 2009, v. 146, n. 6, p. 627, doi. 10.1111/j.1365-2141.2009.07809.x
- By:
- Publication type:
- Article
Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 4, p. 496, doi. 10.1111/j.1365-2141.2008.07369.x
- By:
- Publication type:
- Article